跳至主要内容
临床试验/NCT05256121
NCT05256121招募中不适用

HAPPCAP-AD (Human-APPlication Combined Approach for Prevention of Alzheimer's Disease

Sheba Medical Center2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年6月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2
主要终点
"Risk factors log" response rate

研究概览

简要总结

Currently, Alzheimer's disease (AD) has no cure putting prevention-strategies in the forefront for impeding the public health and personal consequences of this devastating disease. Seven major potentially modifiable risk factors show consistent association with AD (midlife type 2 diabetes [T2D], midlife hypertension, midlife obesity, physical inactivity, depression, smoking, and low educational attainment), with combined population-attributable risk of 30%1. A recent extensive literature review of randomized control trials on single lifestyle interventions for AD yielded negative results. The multidomain preDIVA2,3 (Prevention of Dementia by Intensive Vascular Care) and MAPT4,5 (Multidomain Alzheimer Prevention Trial) studies raised concerns regarding the multidomain approach. The multidomain lifestyle model approach of the FINGER6,7 study (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) brought some optimism after it presented positive results; several replication trials around the world have been launched8. However, 1) all trials focus on the elderly, 2) the impact of midlife risk factors on dementia risk is stronger than late life, and 3) the neurodegenerative changes in AD begin decades before its clinical manifestations9. A recent study showed that 2 or more cardiovascular risk factors in midlife (but not late life) predicted amyloid aggregation10.

Main goals:

To examine the feasibility and provide pilot data on effectiveness of a novel "real-life" personalized 18-months intervention for prevention of cognitive decline in middle-aged individuals (age 40-65-year-old) at high AD risk due to AD parental family history. We will implement an approach "diary-monitoring" ("Risk factors log" which will filled daily by participants, using the REDCap (Research Electronic Data Capture) software's survey) with study team guidance. We hypothesize that daily risk-factors documentation in personal "Risk factors log" will increase participant's engagement in the intervention and will enable the study team to accumulate health information, in order to improve support and counselling for improvement of risk factors. In addition to examining the feasibility of our approach, we will explore its effectiveness in both improving risk factors values, as well as improving cognitive function by comparing the HAPPCAP-AD intervention group to "control group". Last, our study will lay the foundations for a strong long-term large-scale preventive intervention in the future. We will compare this group to a partially passive control.

详细描述

To examine the feasibility and provide pilot data on effectiveness of a novel "real-life" personalized 18-months intervention for prevention of cognitive decline in middle-aged individuals (age 40-65-year-old) at high AD risk due to AD parental family history. We will implement an approach "diary-monitoring" ("Risk factors log" which will filled daily by participants, using the REDCap (Research Electronic Data Capture) software's survey) with study team guidance. We hypothesize that daily risk-factors documentation in personal "Risk factors log" will increase participant's engagement in the intervention and will enable the study team to accumulate health information, in order to improve support and counselling for improvement of risk factors. In addition to examining the feasibility of our approach, we will explore its effectiveness in both improving risk factors values, as well as improving cognitive function by comparing the HAPPCAP-AD intervention group to "control group". Last, our study will lay the foundations for a strong long-term large-scale preventive intervention in the future. We will compare this group to a partially passive control.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Age 40-65 at enrollment to the study
  • Family history of AD-All subjects recruited will have at least 1 parent diagnosed with AD (as specified below)
  • All participant will be MHS (Maccabi Health System) members
  • Participants must have at least two of the seven risk factors for AD (
  • type 2 diabetes [T2D];
  • Hypertension;
  • obesity/ overweight;
  • low physical inactivity;
  • low educational attainment/ mental activity;
  • depression)
  • No dementia diagnosis
  • Hebrew fluency

排除标准

  • Previously diagnosed dementia•
  • Any condition expected to limit the adherence to suggested intervention for 18 months
  • Any significant neurologic or psychiatric disease

结局指标

主要结局

"Risk factors log" response rate

时间窗: 18 months

"Risk factors log" response rate will be measured as an adherence to the intervention surrogate (response rate will be calculated as the number of submitted daily "Risk factors logs" divided by number of days in the study)

次要结局

  • Percent of number of smoked cigarettes' modification in "unbalanced" participants(18 months)
  • Percent of systolic blood pressure values modification in "unbalanced" participants(18 months)
  • Change of the memory domain(18 months)
  • Change of the language domain(18 months)
  • Global cognitive function change(18 months)
  • Percent of weekly physical activity time modification in "unbalanced" participants(18 months)
  • Percent of Body Mass Index (BMI) modification in "unbalanced" participants(18 months)
  • Change of the attention domain(18 months)
  • Percent of HBA1C% values modification in "unbalanced" participants(18 months)
  • Percent of depression modification in "unbalanced" participants(18 months)
  • Change of the executive function domain(18 months)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

HAPPCAP-AD (Human-APPlication Combined Approach for... | 临床试验